The prevalence and burden of interstitial lung diseases in the USA

Niranjan Jeganathan, Matheni Sathananthan
ERJ Open Research 2022 8: 00630-2021; DOI: 10.1183/23120541.00630-2021

Article Information

vol. 8 no. 1
DOI 
https://doi.org/10.1183/23120541.00630-2021
PubMed 
35141319
Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received September 3, 2021
  • Accepted November 21, 2021
  • Published online February 7, 2022.

Article Versions

Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Niranjan Jeganathan1⇑ and
  2. Matheni Sathananthan2
  1. 1Dept of Medicine, Division of Pulmonary, Critical Care, Hyperbaric, Allergy and Sleep Medicine, Loma Linda University Health, Loma Linda, CA USA
  2. 2Dept of Medicine, Loma Linda University Health, Loma Linda, CA USA
  1. Niranjan Jeganathan (njeganathan{at}llu.edu)
View Full Text

Article usage

Article usage: December 2021 to April 2023

AbstractFullPdf
Dec 2021535127
Jan 2022203667
Feb 2022715184
Mar 2022118247
Apr 2022618489
May 2022518058
Jun 2022618353
Jul 2022321068
Aug 2022121041
Sep 2022024254
Oct 2022124839
Nov 2022519848
Dec 2022710041
Jan 2023113145
Feb 2023414829
Mar 2023120955
Apr 2023711741

Altmetrics

Back to top
Email
Print
Citation Tools
The prevalence and burden of interstitial lung diseases in the USA
Niranjan Jeganathan, Matheni Sathananthan
ERJ Open Research Jan 2022, 8 (1) 00630-2021; DOI: 10.1183/23120541.00630-2021
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

Subjects